40th Annual J.P. Morgan Healthcare Conference Presentation

2014-2019 M&A: Built Our Filtration and Analytics Franchises Acquisition year Revenue "First full year" Revenue Growth June 2014 Resulting Franchises R REPLIGEN Refine TECHNOLOGY TANGENX December 2016 ~$10.6 M +48% FY 2015 August 2017 $5.8M +37% FY 2017 FILTRATION ~$400M in 2021e SPECTRUM LABS.COM 2021e figures above are based on 10/28/21 guidance $37M* +37% FY 2018 * Excluding $4M in sales to Repligen 0.000 May 2019 C C TECHNOLOGIES, INC. $25.6 +30% FY 2020 ANALYTICS ~$45M in 2021e FlowVPX Puss 1 8

View entire presentation